Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its upcoming inclusion in the Russell 3000® Index and the Russell 2000® Index following the annual reconstitution of the Russell indexes. This …
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) reported an impressive 84% revenue increase to $32.0 million for the first quarter of 2025, attributed primarily to the acquisition of Greenbrook TMS. …
Neuronetics Posts Strong Revenue Growth in Q1 2025 Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week the granting of inducement awards of Restricted Stock Units (RSUs) totaling 4,500 shares of the Company’s common stock to three …
Neuronetics Announces Inducement Awards for New Team Members Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced it will release its first quarter 2025 financial and operating results before market open on Tuesday, May 6, 2025.
Neuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6 Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its coverage of NeuroStar® …
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has updated its financial results for the fourth quarter and full-year ending December 31, 2024, reflecting revisions related to its acquisition of Greenbrook TMS …
Neuronetics Revises Financial Results for Q4 and Full Year 2024 Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its 2024 financial results, detailing significant operational progress and strategic milestones, including the acquisition of Greenbrook TMS, FDA clearance for adolescent …
Neuronetics Reports 2024 Financial Results and Strategic Advances Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to three recently hired non-executive employees. These awards, …
Neuronetics Grants Inducement Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced the issuance of Restricted Stock Units (RSUs) as part of inducement awards granted to two newly hired non-executive employees. The awards cover …
Neuronetics Announces Stock Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More